Integrated Transcriptomics Establish Macrophage Polarization Signatures and have Potential Applications for Clinical Health and Disease

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Becker, Matheus ^a,b   De Bastiani, Marco A ^a,b   Parisi, Mariana M ^a   Guma, Fátima T C R ^a   Markoski, Melissa M ^c   Castro, Mauro A A ^b   Kaplan, Mark H ^d   Barbé Tuana, Florencia M ^a,e   Klamt, Fábio ^a,b  

^a Instituto de Ciencias Biologicas e da Saude Pontifical Catholic University of Minas Gerais   (Brazil)

^b National Institutes of Science and Technology Translational Medicine ^*  (Brazil)

^c INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MACROPHAGE ACTIVATING FACTOR; TRANSCRIPTOME;

CELL CULTURE; CLASSIFICATION; CYTOLOGY; FEASIBILITY STUDY; GENE EXPRESSION PROFILING; HUMAN; IMMUNOLOGY; MACROPHAGE; MACROPHAGE ACTIVATION; PROCEDURES; SYSTEM ANALYSIS;

CELLS, CULTURED; CYTOKINES; FEASIBILITY STUDIES; GENE EXPRESSION PROFILING; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGE-ACTIVATING FACTORS; MACROPHAGES; SYSTEMS INTEGRATION; TRANSCRIPTOME;

EID: 84940055414     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13351     Document Type: Article

References (62)

1. Wynn, T. A., Chawla, A. & Pollard, J. W. Macrophage biology in development, homeostasis and disease. Nature 496, 445-455, doi: 10.1038/nature12034 (2013).
2. Biswas, S. K., Chittezhath, M., Shalova, I. N. & Lim, J.-Y. Macrophage polarization and plasticity in health and disease. Immunol Res 53, 11-24 (2012).
3. Jaiswal, S., Chao, M. P., Majeti, R. & Weissman, I. L. Macrophages as mediators of tumor immunosurveillance. Trends immunol 31, 212-219 (2010).
4. Nathan, C. & Ding, A. Nonresolving inflammation. Cell 140, 871-882, doi: 10.1016/j.cell.2010.02.029 (2010).
5. Pollard, J. W. Trophic macrophages in development and disease. Nat Rev Immunol 9, 259-270, doi: 10.1038/nri2528 (2009).
6. Jantsch, J., Binger, K. J., Muller, D. N. & Titze, J. Macrophages in homeostatic immune function. Front Physiol 5, 146, doi: 10.3389/fphys.2014.00146 (2014).
7. Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A. & Locati, M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229, 176-185, doi: 10.1002/path.4133 (2013).
8. Allavena, P., Sica, A., Garlanda, C. & Mantovani, A. The Yin-Yang of tumor-Associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 222, 155-161, doi: 10.1111/j.1600-065X.2008.00607.x (2008).
9. Haschemi, A. et al. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab 15, 813-826, doi: 10.1016/j.cmet.2012.04.023 (2012).
10. Kostyk, A. G. et al. Regulation of chemokine expression by NaCl occurs independently of cystic fibrosis transmembrane conductance regulator in macrophages. Am J Pathol 169, 12-20, doi: 10.2353/ajpath.2006.051042 (2006).
11. Mantovani, A. & Locati, M. Orchestration of macrophage polarization. Blood 114, 3135-3136, doi: 10.1182/blood-2009-07-231795 (2009).
12. Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends immunol 25, 677-686 (2004).
13. Hucke, S., Eschborn, M., Engbers, A., Wiendl, H. & Klotz, L. Sodium chloride-high diet promotes pro-inflammatory macrophage activation and aggravates central nervous system autoimmunity. J Neuroimmunol 275, 153 (2014).
14. Xue, J. et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40, 274-288, doi: 10.1016/j.immuni.2014.01.006 (2014).
15. Murray, P. J. et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14-20, doi: 10.1016/j.immuni.2014.06.008 (2014).
16. Balhara, J. & Gounni, A. S. The alveolar macrophages in asthma: a double-edged sword. Mucosal Immunol 5, 605-609, doi: 10.1038/mi.2012.74 (2012).
17. da Rocha, R. F., De Bastiani, M. A. & Klamt, F. Bioinformatics approach to evaluate differential gene expression of M1/M2 macrophage phenotypes and antioxidant genes in atherosclerosis. Cell Biochem Biophys 70, 831-839, doi: 10.1007/s12013-014-9987-3 (2014).
18. Moore, K. J., Sheedy, F. J. & Fisher, E. A. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 13, 709-721, doi: 10.1038/nri3520 (2013).
19. Ramanathan, S. & Jagannathan, N. Tumor associated macrophage: a review on the phenotypes, traits and functions. Iran J Cancer Prev 7, 1-8 (2014).
20. Ruffell, B., Affara, N. I. & Coussens, L. M. Differential macrophage programming in the tumor microenvironment. Trends Immunol 33, 119-126, doi: 10.1016/j.it.2011.12.001 (2012).
21. Solinas, G. et al. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J Immunol 185, 642-652, doi: 10.4049/jimmunol.1000413 (2010).
22. Beyer, M. et al. High-resolution transcriptome of human macrophages. PLoS One 7, e45466, doi: 10.1371/journal.pone.0045466 (2012).
23. Mehraj, V. et al. Monocyte responses in the context of Q fever: from a static polarized model to a kinetic model of activation. J Infect Dis 208, 942-951, doi: 10.1093/infdis/jit266 (2013).
24. Castro, M. A. et al. ViaComplex: software for landscape analysis of gene expression networks in genomic context. Bioinformatics 25, 1468-1469, doi: 10.1093/bioinformatics/btp246 (2009).
25. Reynier, F. et al. Gene expression profiles in alveolar macrophages induced by lipopolysaccharide in humans. Mol Med 18, 1303 (2012).
26. Chamberland, A., Madore, A.-M., Tremblay, K., Laviolette, M. & Laprise, C. A comparison of two sets of microarray experiments to define allergic asthma expression pattern. Exp lung res 35, 399-410 (2009).
27. Gordon, S. Alternative activation of macrophages. Nat Rev Immunol 3, 23-35 (2003).
28. Humbert, M. et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 154, 1497-1504, doi: 10.1164/ajrccm.154.5.8912771 (1996).
29. Becker, M., Muller, C. B., De Bastiani, M. A. & Klamt, F. The prognostic impact of tumor-Associated macrophages and intratumoral apoptosis in non-small cell lung cancer. Histol Histopathol 29, 21-31 (2014).
30. Wu, J. Q., Sasse, T. R., Saksena, M. M. & Saksena, N. K. Transcriptome analysis of primary monocytes from HIV-positive patients with differential responses to antiretroviral therapy. Virol J 10, 361, doi: 10.1186/1743-422X-10-361 (2013).
31. Wynn, J. L. et al. The influence of developmental age on the early transcriptomic response of children with septic shock. Mol Med 17, 1146-1156, doi: 10.2119/molmed.2011.00169 (2011).
32. Voraphani, N. et al. An airway epithelial iNOS-DUOX2-thyroid peroxidase metabolome drives Th1/Th2 nitrative stress in human severe asthma. Mucosal Immunol 7, 1175-1185, doi: 10.1038/mi.2014.6 (2014).
33. Martinez, F. O. & Gordon, S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 6, 13, doi: 10.12703/P6-13 (2014).
34. Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J. & Hill, A. M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164, 6166-6173 (2000).
35. Yang, J., Zhang, L., Yu, C., Yang, X. F. & Wang, H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res 2, 1, doi: 10.1186/2050-7771-2-1 (2014).
36. Biswas, S. K. & Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11, 889-896, doi: 10.1038/ni.1937 (2010).
37. Martinez, F. O., Gordon, S., Locati, M. & Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. The J Immunol 177, 7303-7311 (2006).
38. Baixeras, E. et al. Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens. J Exp Med 176, 327-337 (1992).
39. Triebel, F. et al. LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med 171, 1393-1405 (1990).
40. Buisson, S. & Triebel, F. LAG-3 (CD223) reduces macrophage and dendritic cell differentiation from monocyte precursors. Immunology 114, 369-374, doi: 10.1111/j.1365-2567.2004.02087.x (2005).
41. Johansson, P. et al. Characterisation and expression analysis of the rainbow trout (Oncorhynchus mykiss) homologue of the human dendritic cell marker CD208/lysosomal associated membrane protein 3. Dev Comp Immunol 37, 402-413, doi: 10.1016/j. dci.2012.02.012 (2012).
42. Smith, A. M. et al. Disruption of macrophage pro-inflammatory cytokine release in Crohn's disease is associated with reduced optineurin expression in a subset of patients. Immunology 144, 45-55, doi: 10.1111/imm.12338 (2015).
43. Newman, A. C. & Hughes, C. C. Macrophages and angiogenesis: a role for Wnt signaling. Vasc Cell 4, 13, doi: 10.1186/2045-824X-4-13 (2012).
44. Malik, M. et al. Inducible NOS-induced chloride intracellular channel 4 (CLIC4) nuclear translocation regulates macrophage deactivation. Proc Natl Acad Sci U S A 109, 6130-6135, doi: 10.1073/pnas.1201351109 (2012).
45. Sa, Q. & Hoover-Plow, J. L. EMILIN2 (Elastin microfibril interface located protein), potential modifier of thrombosis. Thromb J 9, 9, doi: 10.1186/1477-9560-9-9 (2011).
46. Arias, J. et al. Increased expression of cytokines, soluble cytokine receptors, soluble apoptosis ligand and apoptosis in dengue. Virology 452-453, 42-51, doi: 10.1016/j.virol.2013.12.027 (2014).
47. Warke, R. V. et al. TRAIL is a novel antiviral protein against dengue virus. J Virol 82, 555-564, doi: 10.1128/JVI.01694-06 (2008).
48. Limonta, D. et al. Apoptotic mediators in patients with severe and non-severe dengue from Brazil. J Med Virol 86, 1437-1447, doi: 10.1002/jmv.23832 (2014).
49. Wong, K. L. et al. Susceptibility and response of human blood monocyte subsets to primary dengue virus infection. PLoS One 7, e36435, doi: 10.1371/journal.pone.0036435 (2012).
50. Lenschow, D. J. et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci USA 104, 1371-1376, doi: 10.1073/pnas.0607038104 (2007).
51. Okumura, A., Lu, G., Pitha-Rowe, I. & Pitha, P. M. Innate antiviral response targets HIV-1 release by the induction of ubiquitinlike protein ISG15. Proc Natl Acad Sci USA 103, 1440-1445, doi: 10.1073/pnas.0510518103 (2006).
52. Hishiki, T. et al. Interferon-mediated ISG15 conjugation restricts dengue virus 2 replication. Biochem Biophys Res Commun 448, 95-100, doi: 10.1016/j.bbrc.2014.04.081 (2014).
53. Alagarasu, K. et al. Polymorphisms in the oligoadenylate synthetase gene cluster and its association with clinical outcomes of dengue virus infection. Infect Genet Evol 14, 390-395, doi: 10.1016/j.meegid.2012.12.021 (2013).
54. Thamizhmani, R. & Vijayachari, P. Association of dengue virus infection susceptibility with polymorphisms of 2'-5'-oligoadenylate synthetase genes: a case-control study. Braz J Infect Dis 18, 548-550, doi: 10.1016/j.bjid.2014.03.004 (2014).
55. Lin, R. J. et al. Distinct antiviral roles for human 2' ,5'-oligoadenylate synthetase family members against dengue virus infection. J Immunol 183, 8035-8043, doi: 10.4049/jimmunol.0902728 (2009).
56. Brass, A. L. et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243-1254, doi: 10.1016/j.cell.2009.12.017 (2009).
57. Ding, S., Pan, Q., Liu, S. L. & Liang, C. HIV-1 mutates to evade IFITM1 restriction. Virology 454-455, 11-24, doi: 10.1016/j. virol.2014.01.020 (2014).
58. Barbe-Tuana, F. M. et al. CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets. Diabetes 55, 2437-2445, doi: 10.2337/db05-1673 (2006).
59. Meyers, D. A. Genetics of asthma and allergy: what have we learned? J Allergy Clin Immunol 126, 439-446; quiz 447-438, doi: 10.1016/j.jaci.2010.07.012 (2010).
60. Barrett, T. et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 41, D991-995, doi: 10.1093/nar/gks1193 (2013).
61. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102, 15545-15550, doi: 10.1073/pnas.0506580102 (2005).
62. Hooper, S. D. & Bork, P. Medusa: a simple tool for interaction graph analysis. Bioinformatics 21, 4432-4433, doi: 10.1093/bioinformatics/bti696 (2005).